Biotime Sells some OCX shares
BioTime sells partial stake in OncoCyte for $4.5M; shares up 8% after hours
Jul. 2, 2019 4:35 PM ET|About: BioTime, Inc. (BTX)|By: Douglas W. House, SA News Editor
BioTime (NYSEMKT:BTX) is up 8% after hours following its announcement that it has agreed to sell 2.25M OncoCyte (NYSEMKT:OCX) shares at $2 per share, yielding gross proceeds of $4.5M. The transaction should close on July 5.
The value of BTX's remaining stake is ~$24.6M.
OCX closed today at $1.98.